StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SCTXVery BullishAnalyst Target Updateanalyst
High materiality8/10

Scribe Therapeutics initiated with a Buy at H.C. Wainwright

Aug 31, 2026, 5:02 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

H.C. Wainwright initiates SCTX with Buy; target $60; price $28.44; priceChangeSinceSignal +7.38.

  • H.C. Wainwright initiates SCTX with Buy; target $60; price $28.44.

Key facts

  1. 01

    Target: $60

  2. 02

    Posted price: $28.44

  3. 03

    Analyst firm: H.C. Wainwright

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.